Roche will help generic drug makers make HIV drug

Drug maker Roche Holding AG said on Thursday it would help generic drug makers in the developing world produce versions of HIV drug saquinavir.

Roche will offer manufacturers in sub-Saharan Africa and the world’s least developed countries the technical expertise they need to make the drug, which is recommended by the World Health Organisation (WHO) to treat the virus that leads to AIDS.

Saquinavir is a protease inhibitor, one of a class of drugs that works by blocking part of the virus and preventing it from replicating.

Protease inhibitors are used in combination with other anti-HIV drugs to reduce the amount of HIV in the body.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   UGA ecologist finds another cause of antibiotic resistance   New drug for neuroblastoma shows promise in phase I study   Baclofen shows promise in patients with alcohol-induced liver disease   Findings point to an ‘off switch’ for drug resistance in cancer   Stopping statins may benefit terminally ill patients   Cholesterol drug users may use pills as a license to overeat   Pfizer lung cancer drug beats chemo for previously untreated patients   Mass. General study identifies path to safer drugs for heart disease, cancer   Gates Foundation awards Notre Dame $23 million for malaria, dengue studies   Cancer drug protects against diabetes   Malaria drug target raises hopes for new treatments